Cargando…
Design, synthesis and molecular mechanisms of novel dual inhibitors of heat shock protein 90/phosphoinositide 3-kinase alpha (Hsp90/PI3Kα) against cutaneous melanoma
Overexpression of heat shock protein 90 (Hsp90) is common in various types of cancer. In cutaneous melanoma, a cancer with one of the high levels of Hsp90 overexpression, such expression was correlated with a panel of protein kinases, thus offering an opportunity to identify Hsp90-based multi-kinase...
Autores principales: | Qin, Feifei, Wang, Yali, Jiang, Xian, Wang, Yujia, Zhang, Nan, Wen, Xiang, Wang, Lian, Jiang, Qinglin, He, Gu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853710/ https://www.ncbi.nlm.nih.gov/pubmed/30957641 http://dx.doi.org/10.1080/14756366.2019.1596903 |
Ejemplares similares
-
Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021) -
Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma
por: Tas, Faruk, et al.
Publicado: (2017) -
Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016) -
Targeting secreted heat shock protein-90alpha (Hsp90α) to prevent breast cancer progression
por: Zhao, Zhengwei, et al.
Publicado: (2010) -
Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer
por: Zagouri, Flora, et al.
Publicado: (2012)